6533b828fe1ef96bd1288c59
RESEARCH PRODUCT
No effect of length time bias on the genomic risk in ER+ HER2-stage I-IIA breast cancer (BC) patients according to diagnosis in a screening programme: An exploratory analysis
D. SalasJ.a. Perez FidalgoI. Gonzalez BarralloCristina HernandoJ.v. SorlíJudith Begoña RamírezOctavio BurguesA. LluchOlga Portoléssubject
Screening programmeOncologymedicine.medical_specialtyBreast cancerOncologybusiness.industryInternal medicineMedicineHematologyExploratory analysisLength time biasbusinessmedicine.diseaseyear | journal | country | edition | language |
---|---|---|---|---|
2018-10-01 | Annals of Oncology |